CFTR ΔF508 carrier status, risk of breast cancer before the age of 40 and histological grading in a population‐based case‐control study

No abstract is available for this paper.

• Publication year

  1998

• Venue

  International Journal of Cancer

• Publication date

  1998-10-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-0215(19981023)79:5<487::AID-IJC7>3.0.CO;2-X
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Cystic Fibrosis

  2009cited by this paper
• Expert Commentary.

  2002cited by this paper
• Pathological prognostic factors in breast cancer.

  1999cited by this paper
• BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer

  1999cited by this paper
• Estrogen receptor polymorphism at codon 325 and risk of breast cancer in women before age forty.

  1998cited by this paper
• Frequency of breast cancer attributable to BRCA1 in a population-based series of American women.

  1998cited by this paper
• Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases

  1997cited by this paper
• AT-tributable risks?

  1997cited by this paper
• Primary pulmonary sarcoma with morphologic features of monophasic synovial sarcoma and chromosome translocation t(X; 18).

  1996cited by this paper
• Cystic fibrosis hetero–and homozygosity is associated with inhibition of breast cancer growth

  1996cited by this paper
• Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer.

  1996cited by this paper
• Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage

  1996cited by this paper
• The feasibility of retrospective grading of breast cancer histology slides derived from multiple pathology services

  1995cited by this paper
• The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group.

  1995cited by this paper
• Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma.

  1995cited by this paper
• The cystic fibrosis transmembrane conductance regulator is a dual ATP and chloride channel.

  1994cited by this paper
• Background, rationale and protocol for a case-control-family study of breast cancer

  1994cited by this paper
• Frequency of carriers of cystic fibrosis gene among patients with myeloid malignancy and melanoma.

  1991cited by this paper
• Identification of the cystic fibrosis gene: genetic analysis

  1989cited by this paper
• Computing an Exact Confidence Interval for the Common Odds Ratio in Several 2×2 Contingency Tables

  1985cited by this paper
• Growth inhibition of human tumor cells in soft-agar cultures by treatment with low levels of adenosine 5'-triphosphate.

  1983cited by this paper

• Epithelial–Mesenchymal Transition Mechanisms in Chronic Airway Diseases: A Common Process to Target?

  2023cites this paper
• Incidence of breast cancer in people with cystic fibrosis: A cause for concern?

  2021cites this paper
• What Role Does CFTR Play in Development, Differentiation, Regeneration and Cancer?

  2020cites this paper
• A bird eye view on cystic fibrosis: An underestimated multifaceted chronic disorder.

  2020cites this paper
• Pathological role of ion channels and transporters in the development and progression of triple-negative breast cancer

  2020cites this paper
• Cystic fibrosis transmembrane conductance regulator—emerging regulator of cancer

  2018cites this paper
• Family specific genetic predisposition to breast cancer: results from Tunisian whole exome sequenced breast cancer cases

  2018cites this paper
• CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer

  2013cites this paper
• Downregulation of CFTR promotes epithelial-to-mesenchymal transition and is associated with poor prognosis of breast cancer.

  2013cites this paper
• Cystic fibrosis transmembrane conductance regulator gene mutation and lung cancer risk.

  2010cites this paper
• Cancer risk among patients with cystic fibrosis and their first‐degree relatives

  2009cites this paper
• Cystic fibrosis transmembrane conductance regulator (CFTR) gene 5T allele may protect against prostate cancer: a case-control study in Chinese Han population.

  2008cites this paper
• Investigating the phenotypes and genotypes of breast cancer in women with African ancestry: the need for more genetic epidemiology.

  2007cites this paper
• Cystic fibrosis adult care: consensus conference report.

  2004cites this paper
• Polymorphisms of SPINK1 N34S and CFTR in Patients with Sporadic and Familial Pancreatic Cancer

  2003cites this paper
• Consensus Conference Report

  2002cites this paper
• Cystic fibrosis heterozygosity: Darwinian bet on cancer protection?

  2002cites this paper
• Adenosine-triphosphate in trauma-related and elective hypothermia.

  1999cites this paper
• Pharmacogenomics of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and the Cystic Fibrosis Drug CPX Using Genome Microarray Analysis

  1999cites this paper